Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa
Evaluating the Efficacy of Radically Open Dialectical Behaviour Therapy (RO-DBT) in Patients With Anorexia Nervosa: a Randomized Controlled Clinical Trial
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
96 participants
Jun 22, 2023
INTERVENTIONAL
Conditions
Summary
Randomized controlled clinical trial to evaluate the efficacy of "Radically Open Dialectical Behaviour Therapy" in patients with eating disorders: a proof-of-concept study.
Eligibility
Inclusion Criteria5
- female patients
- aged between 18 to 65 years old,
- having a diagnosis of AN (DSM 5 criteria),
- having had weigh restoration treatment (normal BMI considered >19 kg/m2)
- having an overcontrol personality style assessed with the styles of coping Word-Pair Checklist scale (ASC-WP)
Exclusion Criteria7
- diagnosis of severe mental illness (schizophrenia or other psychosis, bipolar disorder, major depressive disorder, substance use disorder)
- diagnosis of borderline personality disorder (BPD) or positive result in McLean Screening Instrument for BPD
- mental retardation
- being under standardized psychotherapy at the baseline
- being illiterate or not able to understand Spanish language,
- being left-handed
- being pregnant for MRI requirements.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
RO-DBT is a transdiagnostic intervention specifically designed to treat a spectrum of disorders characterized by excessive overcontrol such as resistant depression, avoidant and obsessive-compulsive personality disorders, mood disorders, anorexia nervosa and autism spectrum disorder.
he TAU condition will follow the standard treatment of the EDs Unit of the HSCSP for AN. This treatment consists of visits with a psychiatrist with a frequency decided according to the clinical situation and, in some cases, nursing follow-up and/or relapse prevention group that takes place twice per month
All controls will complete data collection notebook and will undergo the same neuroimaging acquisition. There will not be follow-up for this group.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06050421